research use only
Cat.No.S8570
| Related Targets | EGFR VEGFR PDGFR FGFR c-Met Src MEK CSF-1R FLT3 HER2 |
|---|---|
| Other Axl Inhibitors | Bemcentinib (R428) Dubermatinib(TP-0903) LDC1267 UNC2025 HCl Tamnorzatinib (ONO-7475) SGI-7079 RU-301 PF-07265807 |
|
In vitro |
DMSO
: 10 mg/mL
(16.99 mM)
Ethanol : 2 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 588.56 | Formula | C31H26F2N4O6 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 1437321-24-8 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CC(C)N1C=C(C(=O)N(C1=O)C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C5C=C(C(=CC5=NC=C4)OC)OC)F | ||
| Targets/IC50/Ki |
Axl
(Cell-free assay) 7 nM
c-Met
(Cell-free assay) 12 nM
Tyro3
(Cell-free assay) 19 nM
MER
(Cell-free assay) 29 nM
Tyro3
(Cell-free assay) 29 nM
VEGFR2
(Cell-free assay) 960 nM
|
|---|---|
| In vitro |
RXDX-106 inhibits TAM and c-MET phosphorylation in vitro. This inhibition of TAM and c-MET activation in vitro is accompanied by a decrease in downstream MAPK and PI3K signaling and cell viability. It completely inhibits cellular proliferation and viability at sub-nanomolar concentrations in TAM-expressing cells.
|
| In vivo |
RXDX-106 could inhibit tumors harboring activating TAM gene fusions and affect the TAM-expressing tumor microenvironment to result in a global anti-cancer environment.
|
References |
|
| Methods | Biomarkers | Images | PMID |
|---|---|---|---|
| Western blot | p-MerTK / MerTK / p-ERK / ERK / p-AKT / AKT |
|
29285287 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.